Barrera, Xyrus .

HRN: 28-64-35  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2026
MUPIROCIN 2%, 15G (TUBE)
03/03/2026
03/09/2026
TOPICAL
2%
BID
Furuncle
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: